| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.094 | 0.05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.089 | 0.05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |